Spengler neotens NEO300 Gebrauchsanweisung Seite 54

BLOOD PRESSURE INFORMATION
The European Society of Cardiology (ESC) defined different levels of blood pressure based on clinical trials and meta-analy-
ses. The prerequisite of Blood Pressure measurement is that it must be undertaken using an accurate device that has been
clinically validated. The blood pressure measurement and its monitoring can be performed at patient home; however, the hy-
pertension diagnoses will be established by the doctor at his/her office. According to the environment where the measurement
is made, the thresholds test values for elevated pressure or hypertension may vary. The ESC proposed table below summarizes
those thresholds at the doctor office or at home.
Non-elevated blood
pressure
Office BP
SBP < 120 mmHg
DBP < 70 mmHg
Home BP
SBP <120 mmHg
DBP < 70 mmHg
Insufficient evidence
confirming the efficacy and
safety of BP pharmacological
treatment
Source: Blood pressure categories. McEvoy, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur. Heart Journal.
BP, blood pressure; DBP, diastolic blood pressure; SBP, systolic blood pressure.
Do not be alarmed if an abnormal reading occurs. A better indication of an individual's blood pressure occurs after 2-3
readings taken at the same time each day over an extended period of time. Consult your doctor if test results remain
abnormal.
54
USER MANUAL NEOTENS | WWW.SPENGLER.FR
Elevated blood
pressure
Office BP
SBP 120 - 139 mmHg
and or
DBP 70 - 89 mmHg
Home BP
SBP 120 - 134 mmHg
and or
DBP 70 - 84 mmHg
Risk stratify to identify
individuals with high
cardiovascular risk for PB
pharmacological treatment.
.
Hypertension
Office BP
SBP ≥ 140 mmHg
or
DBP ≥ 90 mmHg
Home BP
SBP ≥ 135 mmHg
or
DBP ≥ 85 mmHg
Cardiovascular risk is
sufficiently high to merit BP
pharmacological treatment
initiation.